Sandra Chuang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sandra Chuang has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Adam Jaffe
School of Clinical Medicine, Discipline of Paediatrics and Child Health, University of New South Wales , Sydney
9 shared publications - Chee Yee Ooi
Molecular and Integrative Cystic Fibrosis (miCF) Research Centre UNSW Sydney Sydney New South Wales Australia
5 shared publications Hiran Selvadurai
4 shared publications- Bernadette Prentice
Discipline of Paediatrics and Child Health, School of Clinical Medicine University of New South Wales Sydney Australia
3 shared publications - Michael Jonathon Coffey
School of Clinical Medicine, Discipline of Paediatrics & Child Health, Randwick Clinical Campus, UNSW Medicine & Health, University of New South Wales
3 shared publications Adam Jaffe
2 shared publications
Latest Publications
- Open Access
- 3 September 2026
- Published by Elsevier in Journal of Cystic Fibrosis
The cystic fibrosis gut microbial dysbiosis index (CF-GMDI): a quantitative measure of gut microbial imbalance in children with cystic fibrosis
- 3 September 2026
- Published by Elsevier in Journal of Cystic Fibrosis
Open AccessThe cystic fibrosis gut microbial dysbiosis index (CF-GMDI): a quantitative measure of gut microbial imbalance in children with cystic fibrosis
- Open Access
- 18 March 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (3) , 681
The Prevalence of Polyketide Synthase-Positive E. coli in Cystic Fibrosis
Cystic fibrosis (CF) patients experience higher risks of colorectal cancer but the pathogenesis is unclear. In the general population, polyketide synthase-positive (pks+) E. coli is implicated in intestinal carcinogenesis via the production of colibactin; however, the relevance in CF is unknown. In this study, we investigate pks+E. coli prevalence in CF and potential associations between pks+E. coli, gastrointestinal inflammation, and microbiome dynamics with fecal calprotectin and 16SrRNA gene taxonomic data. Cross-sectional analysis demonstrated no difference in pks+E. coli carriage between CF patients and healthy controls, 21/55 (38%) vs. 26/55 (47%), p = 0.32. Pks+E. coli was not associated with significant differences in mean (SD) calprotectin concentration (124 (154) vs. 158 (268) mg/kg; p = 0.60), microbial richness (159 (76.5) vs. 147 (70.4); p = 0.50) or Shannon diversity index (2.78 (0.77) vs. 2.65 (0.74); p = 0.50) in CF. Additionally, there was no association with exocrine pancreatic status (p = 0.2) or overall antibiotic use (p = 0.6). Longitudinally, CF subjects demonstrated intra-individual variation in pks+E. coli presence but no significant difference in overall prevalence. Future investigation into the effects of repeat exposure on risk profile and analysis of older CF cohorts is necessary to identify if associations with colorectal cancer exist.
- 18 March 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (3) , 681
Open AccessThe Prevalence of Polyketide Synthase-Positive E. coli in Cystic Fibrosis
Cystic fibrosis (CF) patients experience higher risks of colorectal cancer but the pathogenesis is unclear. In the general population, polyketide synthase-positive (pks+) E. coli is implicated in intestinal carcinogenesis via the production of colibactin; however, the relevance in CF is unknown. In this study, we investigate pks+E. coli prevalence in CF and potential associations between pks+E. coli, gastrointestinal inflammation, and microbiome dynamics with fecal calprotectin and 16SrRNA gene taxonomic data. Cross-sectional analysis demonstrated no difference in pks+E. coli carriage between CF patients and healthy controls, 21/55 (38%) vs. 26/55 (47%), p = 0.32. Pks+E. coli was not associated with significant differences in mean (SD) calprotectin concentration (124 (154) vs. 158 (268) mg/kg; p = 0.60), microbial richness (159 (76.5) vs. 147 (70.4); p = 0.50) or Shannon diversity index (2.78 (0.77) vs. 2.65 (0.74); p = 0.50) in CF. Additionally, there was no association with exocrine pancreatic status (p = 0.2) or overall antibiotic use (p = 0.6). Longitudinally, CF subjects demonstrated intra-individual variation in pks+E. coli presence but no significant difference in overall prevalence. Future investigation into the effects of repeat exposure on risk profile and analysis of older CF cohorts is necessary to identify if associations with colorectal cancer exist.
- Open Access
- 13 February 2025
- Published by MDPI AG in Preprints.org
The Prevalence of pks+ E. coli in Cystic Fibrosis
Cystic fibrosis (CF) patients experience higher risks of colorectal cancer, but pathogenesis is unclear. In the general population, polyketide synthase-positive (pks+) E. coli is impli-cated in intestinal carcinogenesis via production of colibactin, however relevance in CF is unknown. We investigated pks+ E. coli prevalence in CF at baseline and longitudinally, performing PCR on stool DNA extracts. Potential associations between pks+ E. coli and gastrointestinal inflammation or microbiome dynamics were analysed using faecal calprotectin and 16SrRNA gene taxonomic data. At baseline, no difference in pks+ E. coli carriage was identified between CF and healthy controls, 21/55(38%) vs 26/55(47%), p=0.32. Pks+ E. coli was not associated with significant differences in mean (SD) calpro-tectin concentration (124(154) vs 158(268) mg/kg; p=0.60), microbial richness (159(76.5) vs 147(70.4); p=0.50) or Shannon diversity index (2.78(0.77) vs 2.65(0.74); p=0.50) in CF. Lon-gitudinally, subjects demonstrated intra-individual variation in pks+ E. coli presence, however no significant difference in overall prevalence was observed. Thus, intesti-nal pks+ E. coli prevalence was not different between CF and healthy controls, nor associ-ated with differences in gut microbial profile or inflammation. Investigating effects of re-peat exposure on risk profile and analysis of older CF cohorts is necessary to identify if associations with colorectal cancer exist.
- 13 February 2025
- Published by MDPI AG in Preprints.org
Open AccessThe Prevalence of pks+ E. coli in Cystic Fibrosis
Cystic fibrosis (CF) patients experience higher risks of colorectal cancer, but pathogenesis is unclear. In the general population, polyketide synthase-positive (pks+) E. coli is impli-cated in intestinal carcinogenesis via production of colibactin, however relevance in CF is unknown. We investigated pks+ E. coli prevalence in CF at baseline and longitudinally, performing PCR on stool DNA extracts. Potential associations between pks+ E. coli and gastrointestinal inflammation or microbiome dynamics were analysed using faecal calprotectin and 16SrRNA gene taxonomic data. At baseline, no difference in pks+ E. coli carriage was identified between CF and healthy controls, 21/55(38%) vs 26/55(47%), p=0.32. Pks+ E. coli was not associated with significant differences in mean (SD) calpro-tectin concentration (124(154) vs 158(268) mg/kg; p=0.60), microbial richness (159(76.5) vs 147(70.4); p=0.50) or Shannon diversity index (2.78(0.77) vs 2.65(0.74); p=0.50) in CF. Lon-gitudinally, subjects demonstrated intra-individual variation in pks+ E. coli presence, however no significant difference in overall prevalence was observed. Thus, intesti-nal pks+ E. coli prevalence was not different between CF and healthy controls, nor associ-ated with differences in gut microbial profile or inflammation. Investigating effects of re-peat exposure on risk profile and analysis of older CF cohorts is necessary to identify if associations with colorectal cancer exist.
- 11 December 2023
- Published by Springer Nature in Pediatric Nephrology
- Vol. 39 (5) , 1577-1585
Sleep disturbances in children and adolescents after kidney transplantation
Background Disturbances of sleep are prevalent among children with chronic kidney disease. However, the aetiology of sleep disorders in children particularly after kidney transplantation is not clear. We sought to ascertain the prevalence and type of sleep disturbances in paediatric kidney transplant recipients and to identify predictors of sleep disturbances in this population. Methods Caregivers of kidney transplant recipients completed online questionnaires about their child’s sleep. The questionnaires utilised were the Sleep Disturbance Scale for Children (SDSC), the Epworth Sleepiness Scale for Children and Adolescents (ESS-CHAD), questions about sleep hygiene, and questions about restless leg syndrome. Demographic and clinical details were collected from medical records. Results Thirty-five children were included in the study, with a median (IQR) age of 14.1 years (9.5–16.1) and median years (IQR) since transplant of 3.7 (0.7–8.7) years, and 72.0% were identified to have at least one category of sleep disturbance according to scores on the SDSC. The most common sleep disturbances reported were disorders of initiating and maintaining sleep (DIMS) (40.0%) and disorders of excessive somnolence (DOES) (31.4%). Statistically significant predictors of sleep disturbances include low estimated glomerular filtration rate and increased age. Among children who screened positive for DIMS and DOES, the majority indicated use of electronic devices in 1 h before bed. Conclusions A high prevalence of sleep disturbances has been identified in children after kidney transplants, and some risk factors may be modifiable. Further studies are required to understand whether there are other readily modifiable predictors of sleep disturbances. Graphical Abstract A higher resolution version of the Graphical abstract is available as Supplementary information
- 11 December 2023
- Published by Springer Nature in Pediatric Nephrology
- Vol. 39 (5) , 1577-1585
Sleep disturbances in children and adolescents after kidney transplantation
Background Disturbances of sleep are prevalent among children with chronic kidney disease. However, the aetiology of sleep disorders in children particularly after kidney transplantation is not clear. We sought to ascertain the prevalence and type of sleep disturbances in paediatric kidney transplant recipients and to identify predictors of sleep disturbances in this population. Methods Caregivers of kidney transplant recipients completed online questionnaires about their child’s sleep. The questionnaires utilised were the Sleep Disturbance Scale for Children (SDSC), the Epworth Sleepiness Scale for Children and Adolescents (ESS-CHAD), questions about sleep hygiene, and questions about restless leg syndrome. Demographic and clinical details were collected from medical records. Results Thirty-five children were included in the study, with a median (IQR) age of 14.1 years (9.5–16.1) and median years (IQR) since transplant of 3.7 (0.7–8.7) years, and 72.0% were identified to have at least one category of sleep disturbance according to scores on the SDSC. The most common sleep disturbances reported were disorders of initiating and maintaining sleep (DIMS) (40.0%) and disorders of excessive somnolence (DOES) (31.4%). Statistically significant predictors of sleep disturbances include low estimated glomerular filtration rate and increased age. Among children who screened positive for DIMS and DOES, the majority indicated use of electronic devices in 1 h before bed. Conclusions A high prevalence of sleep disturbances has been identified in children after kidney transplants, and some risk factors may be modifiable. Further studies are required to understand whether there are other readily modifiable predictors of sleep disturbances. Graphical Abstract A higher resolution version of the Graphical abstract is available as Supplementary information
- Open Access
- 14 November 2022
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 8 (4)
Dual CFTR modulator therapy efficacy in the real world: lessons for the future
Stringent analyses caution against drawing conclusions about the real-world efficacy of CFTR modulator therapy too earlyhttps://bit.ly/3dJt6no
- 14 November 2022
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 8 (4)
Open AccessDual CFTR modulator therapy efficacy in the real world: lessons for the future
Stringent analyses caution against drawing conclusions about the real-world efficacy of CFTR modulator therapy too earlyhttps://bit.ly/3dJt6no
- Open Access
- 20 March 2019
- Published by Wiley in Experimental Physiology
- Vol. 104 (5) , 755-764
Quantitative assessment of nocturnal neural respiratory drive in children with and without obstructive sleep apnoea using surface EMG
New Findings: What is the central question of this study? Recent studies have suggested potential utility of non‐normalized respiratory muscle EMG as an index of neural respiratory drive (NRD). Whether NRD measured using non‐normalized surface EMG of the lateral chest wall overlying the diaphragm (sEMGcw) recorded during nocturnal clinical polysomnography can differentiate children with and without obstructive sleep apnoea (OSA) is not known. What is the main finding and its importance? Non‐normalized sEMGcw was increased in children with OSA and an additional group of snoring children without OSA but subjectively increased respiratory effort compared with primary snorers. The sEMGcw has potential clinical utility in evaluation of children with sleep‐disordered breathing as an objective, non‐invasive, non‐volitional marker of NRD. Our aim was to investigate whether neural respiratory drive measured by non‐normalized surface EMG recorded from the chest wall overlying the diaphragm (sEMGcw) differentiates children with and without obstructive sleep apnoea (OSA). Polysomnography data of children aged 0–18 years were divided into the following three groups: (i) primary snorers (PS); (ii) snoring children without OSA but with increased work of breathing (incWOB; subjective physician report of increased respiratory effort during sleep); and (iii) children with OSA [obstructive apnoea–hypopnoea index (OAHI) >1 h−1]. Excerpts of sEMGcw obtained during tidal unobstructed breathing from light, deep and rapid eye movement sleep were exported for quantitative analysis. Overnight polysomnography data from 45 PS [median age 4.4 years (interquartile range 3.0–7.7 years), OAHI 0 h−1 (0.0–0.2 h−1)], 19 children with incWOB [age 2.8 years (2.4–5.7 years), OAHI 0.1 h−1 (0.0–0.4 h−1)] and 27 children with OSA [age 3.6 years (2.6–6.2 years), OAHI 3.7 h−1 (2.3–6.9 h−1)] were analysed. The sEMGcw was higher in those with OSA [8.47 μV (5.98–13.07 μV); P < 0.0001] and incWOB [8.97 μV (5.94–13.43 μV); P < 0.001] compared with PS [4.633 μV (2.98–6.76 μV)]. There was no significant difference in the sEMGcw between children with incWOB and OSA (P = 0.78). Log sEMGcw remained greater in children with OSA and incWOB compared with PS after age, body mass index centiles, sleep stages and sleep positions were included in the mixed linear models (P < 0.0001). The correlation between sEMGcw and OAHI in children without OSA was small (rs = 0.254, P = 0.04). The sEMGcw is increased in children with OSA and incWOB compared with PS.
- 20 March 2019
- Published by Wiley in Experimental Physiology
- Vol. 104 (5) , 755-764
Open AccessQuantitative assessment of nocturnal neural respiratory drive in children with and without obstructive sleep apnoea using surface EMG
New Findings: What is the central question of this study? Recent studies have suggested potential utility of non‐normalized respiratory muscle EMG as an index of neural respiratory drive (NRD). Whether NRD measured using non‐normalized surface EMG of the lateral chest wall overlying the diaphragm (sEMGcw) recorded during nocturnal clinical polysomnography can differentiate children with and without obstructive sleep apnoea (OSA) is not known. What is the main finding and its importance? Non‐normalized sEMGcw was increased in children with OSA and an additional group of snoring children without OSA but subjectively increased respiratory effort compared with primary snorers. The sEMGcw has potential clinical utility in evaluation of children with sleep‐disordered breathing as an objective, non‐invasive, non‐volitional marker of NRD. Our aim was to investigate whether neural respiratory drive measured by non‐normalized surface EMG recorded from the chest wall overlying the diaphragm (sEMGcw) differentiates children with and without obstructive sleep apnoea (OSA). Polysomnography data of children aged 0–18 years were divided into the following three groups: (i) primary snorers (PS); (ii) snoring children without OSA but with increased work of breathing (incWOB; subjective physician report of increased respiratory effort during sleep); and (iii) children with OSA [obstructive apnoea–hypopnoea index (OAHI) >1 h−1]. Excerpts of sEMGcw obtained during tidal unobstructed breathing from light, deep and rapid eye movement sleep were exported for quantitative analysis. Overnight polysomnography data from 45 PS [median age 4.4 years (interquartile range 3.0–7.7 years), OAHI 0 h−1 (0.0–0.2 h−1)], 19 children with incWOB [age 2.8 years (2.4–5.7 years), OAHI 0.1 h−1 (0.0–0.4 h−1)] and 27 children with OSA [age 3.6 years (2.6–6.2 years), OAHI 3.7 h−1 (2.3–6.9 h−1)] were analysed. The sEMGcw was higher in those with OSA [8.47 μV (5.98–13.07 μV); P < 0.0001] and incWOB [8.97 μV (5.94–13.43 μV); P < 0.001] compared with PS [4.633 μV (2.98–6.76 μV)]. There was no significant difference in the sEMGcw between children with incWOB and OSA (P = 0.78). Log sEMGcw remained greater in children with OSA and incWOB compared with PS after age, body mass index centiles, sleep stages and sleep positions were included in the mixed linear models (P < 0.0001). The correlation between sEMGcw and OAHI in children without OSA was small (rs = 0.254, P = 0.04). The sEMGcw is increased in children with OSA and incWOB compared with PS.
- 1 January 2018
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 17 (1) , 109-113
Age-related levels of fecal M2-pyruvate kinase in children with cystic fibrosis and healthy children 0 to 10 years old
- 1 January 2018
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 17 (1) , 109-113
Age-related levels of fecal M2-pyruvate kinase in children with cystic fibrosis and healthy children 0 to 10 years old
- 1 May 2017
- Published by Elsevier in Respiratory Physiology & Neurobiology
- Vol. 239, 75-80
Validation of a quantitative method to measure neural respiratory drive in children during sleep
- 1 May 2017
- Published by Elsevier in Respiratory Physiology & Neurobiology
- Vol. 239, 75-80
Validation of a quantitative method to measure neural respiratory drive in children during sleep
- 1 April 2017
- Published by Elsevier in Gastroenterology
- Vol. 152 (5) , S645-S646
Determining the Age-Related Levels of Fecal M2-Pyruvate Kinase in Children with Cystic Fibrosis During the First Decade of Life
- 1 April 2017
- Published by Elsevier in Gastroenterology
- Vol. 152 (5) , S645-S646
Determining the Age-Related Levels of Fecal M2-Pyruvate Kinase in Children with Cystic Fibrosis During the First Decade of Life
- 31 March 2017
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 53 (5) , 500-502
An unusual case of haemolytic anaemia and failure to thrive in a Burmese refugee baby
- 31 March 2017
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 53 (5) , 500-502
An unusual case of haemolytic anaemia and failure to thrive in a Burmese refugee baby